NCT03545126View on ClinicalTrials.gov

Human CNS Tau Kinetics in Tauopathies

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

March 4, 2022

Study Completion Date

March 4, 2022

Conditions
Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)Frontotemporal Dementia (FTD MAPT Mutation)
Interventions
OTHER

13C6 Leucine

Recruited participants will be given 13C6-labeled leucine through intravenous infusion (4mg/kg/hr for 16hrs)

Trial Locations (1)

63110

Washington University in St. Louis School of Medicine, St Louis

All Listed Sponsors
collaborator

Association of Frontotemporal Degeneration

UNKNOWN

collaborator

Tau Consortium

OTHER

lead

Washington University School of Medicine

OTHER

NCT03545126 - Human CNS Tau Kinetics in Tauopathies | Biotech Hunter | Biotech Hunter